Baset Pharma

Pioneering a New Era of Immunotherapy for Autoimmune Diseases and Cancer

Our Vision

Baset Pharmaceuticals Ltd is pioneering a new era in oncology and autoimmune diseases, dedicated to developing groundbreaking antibody therapies with superior efficacy and safety for patients.

Our long-term vision is to transform cancer treatment by delivering highly specific and potent therapeutic agents, expanding effective options for patients worldwide.

Registered in England and Wales, Baset Pharmaceuticals Ltd is committed to advancing therapeutics through rigorous scientific innovation and a patient-centric approach. We are actively seeking strategic partners to help bring these life-changing therapies to patients in need.

Latest Advancements

Conditional Activation Mechanisms

Feb 2025

Focusing on conditional activation to overcome current treatment limitations.

Multispecific Constructs Optimized

August 2025

We are optimizing multispecific antibody constructs for enhanced efficacy and safety.

Antibody Power

Advanced trispecific and multispecific antibodies for cancer.
Precision Targeting

Pinpointing cancer cells with accuracy.

Novel Combinations

New ways to attack tumors.

Safety First

Minimizing side effects for patients.

☁️ Best offers ☁️ Free delivery ☁️ Perfect design ☁️ Comfort ☁️ Support 24/7 ☁️ Vibes
☁️ Best offers ☁️ Free delivery ☁️ Perfect design ☁️ Comfort ☁️ Support 24/7 ☁️ Vibes
Fund Our Future

Get In Touch

Our Location

Phone: +49 1623977520
Email: ahmed.somaida@basetpharma.com
Address: 73-75 Aldgate High Street, London, England, EC3N 1BD

Working Hours: Monday - Friday: 9 AM - 5 PM